Screener
Axsome Therapeutics AXSM Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's net margin?
- Axsome Therapeutics (AXSM) reported net margin of -26.6% in Q1 2026.
- How has Axsome Therapeutics's net margin changed year-over-year?
- Axsome Therapeutics's net margin increased by 58.7% year-over-year, from -64.4% to -26.6%.
- What is the long-term trend for Axsome Therapeutics's net margin?
- Over 3 years (2022 to 2025), Axsome Therapeutics's net margin has grown at a -57.5% compound annual growth rate (CAGR), from -374% to -28.7%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Axsome Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude